亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

L-賴氨酸鹽酸鹽

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
過(guò)期 長(zhǎng)期有效
更新 2011-05-20 15:55
 

武漢市威順達(dá)科技發(fā)展有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

L-賴氨酸鹽酸鹽

英文產(chǎn)品名稱:L-Lysine monohydrochloride

化學(xué)分子式:C6H14N2O2·HCL

化學(xué)名稱:

特性與用途:白色或近白色自由流動(dòng)性的結(jié)晶性粉末。幾乎無(wú)臭。263~264℃熔化并分解。通常較穩(wěn)定,高濕度60%以下穩(wěn)定,60%以上則生成二水合物。與維生素C和維生素K3共存則易著色。堿性條件及直接與還原糖存在下加熱則分解。易溶于水(40g/ml,35℃),水溶液呈中性至微酸性,與磷酸、鹽酸、氫氧化鈉、離子交換樹(shù)脂等一起加熱,起外消旋作用。賴氨酸為必需氨基酸,無(wú)法在體內(nèi)合成,如缺乏則引起蛋白質(zhì)代謝障礙及功能障礙,導(dǎo)致生長(zhǎng)障礙、發(fā)育不全、體重下降、食欲不振、血中蛋白減少等。D-型賴氨酸無(wú)生理效果。

 

聯(lián)系人:唐鳳霞
電話:027-88774309
傳真:027-88416321
手機(jī):15071094119
郵箱:x88774309@126.com
QQ:422632031
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
氟苯尼考 乳酸甲氧芐啶 鹽酸黃連素 貫葉連翹提取物 鹽酸肼屈嗪 卡托普利 鹽酸蘆氟沙星 鹽酸金霉素
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |